What is the recommended treatment for Trichomonas vaginalis infection?

Treatment of Trichomoniasis

For women, metronidazole 500 mg orally twice daily for 7 days is the preferred first-line treatment, as it achieves superior cure rates (89%) compared to single-dose therapy (81%). 1

First-Line Treatment Regimens

Women (Non-Pregnant)

• Preferred regimen: Metronidazole 500 mg orally twice daily for 7 days 2, 3, 4, 1

  • This multi-day regimen reduces treatment failure at 1-month test-of-cure compared to single-dose therapy (11% vs 19% positive at follow-up) 1
  • Achieves approximately 89-95% cure rates 2, 4, 1

• Alternative regimen: Metronidazole 2 g orally as a single dose 2, 3, 4

  • Reserve for situations where adherence to multi-day therapy is unreliable or cost is a significant barrier 2
  • Achieves approximately 81-90% cure rates 4, 1
  • This should NOT be first-line in non-pregnant women when adherence to 7-day therapy is feasible 2

Men

• Preferred regimen: Metronidazole 2 g orally as a single dose 5
  • The single-dose regimen remains the standard for male patients 5

Pregnant Women

• First trimester: Treatment is contraindicated due to teratogenic risk during fetal organogenesis 2, 3

  • Defer all therapy until after 12 weeks gestation 2, 4

• After first trimester: Metronidazole 2 g orally as a single dose 2, 3

  • The single-dose regimen is specifically recommended to minimize total fetal drug exposure 2
  • Treatment is warranted because trichomoniasis increases risk of premature rupture of membranes, preterm delivery, and low birthweight 2, 3

Critical Partner Management (Mandatory)

All sexual partners must be treated simultaneously with the same metronidazole regimen, regardless of symptom status—failure to do so is the leading cause of treatment failure and reinfection. 2, 3, 4

• Most infected men are asymptomatic carriers, making them unknowing vectors of transmission 2
• Patients must abstain from sexual intercourse until both partners complete treatment and are asymptomatic 2, 3, 4
• Partner treatment is mandatory even without confirmed testing, as untreated partners will reinfect treated patients 2

Treatment Failure Algorithm

First Documented Failure

• Re-treat with metronidazole 500 mg orally twice daily for 7 days 2, 3, 4

Second Documented Failure

• Metronidazole 2 g orally once daily for 3-5 days 2, 3, 4

Persistent or Refractory Infection

• Consult infectious disease specialist for susceptibility testing 2, 4
• Confirm that reinfection from untreated partners has been excluded before pursuing resistance testing 2
• Even strains with reduced susceptibility generally respond to higher metronidazole doses 2
• In vitro resistance to nitroimidazoles remains low (approximately 4-5%) 3, 5

Special Populations

HIV-Infected Patients

• Use the same metronidazole regimens as HIV-negative patients 2, 4

Metronidazole Allergy

• No effective non-nitroimidazole alternatives exist 2, 4
• Desensitization protocols may be required 2, 4

Breastfeeding

• The 7-day regimen may be preferred if the patient cannot interrupt breastfeeding, as lower daily doses result in less drug accumulation in breast milk 4

What NOT to Do (Critical Pitfalls)

• Never use topical metronidazole gel—it achieves less than 50% efficacy and fails to reach therapeutic concentrations in the genital tract 2, 3, 4
• Never treat during the first trimester of pregnancy—metronidazole is contraindicated due to teratogenic risk 2, 3
• Never omit simultaneous partner treatment—this is the primary driver of recurrent infection 2, 3, 4
• Never use single-dose therapy as first-line in non-pregnant women when adherence to 7-day therapy is feasible, as the longer course provides superior cure rates 2, 1
• Never use other topical antimicrobials—all have similarly low cure rates (<50%) 2

Follow-Up Recommendations

• Routine follow-up testing is unnecessary for patients who become asymptomatic after completing therapy 2, 4
• However, rescreening at 3 months after treatment is recommended due to high rates of repeat and persistent infections 5

Patient Counseling Points

• Patients must avoid all alcohol during treatment and for at least 24 hours after the last metronidazole dose to prevent severe disulfiram-like reactions 2
• Sexual activity must cease until both patient and all partners complete therapy and are asymptomatic 2, 3, 4